General Information

Mail: University of Houston
Cullen College of Engineering
E421 Engineering Bldg 2, Houston, TX 77204-4007
Map & Driving Directions (includes parking information)
Email: info [at] egr [dot] uh [dot] edu

News

UH Chem-E Car Team Places Fifth at National Competition

Printer-friendly versionSend by emailPDF version

By: 

Esmeralda Fisher
Members of the UH Chem-E Car Team
Members of the UH Chem-E Car Team

The University of Houston Chem-E Car team competed at the 2012 AIChE National Competition recently, taking fifth place, the highest that UH has achieved at the national level.

Students representing UH were An Dinh (team lead), Edward McDowell, Joshua Dillon, Rishabh Mahajan, Sheli Wilson, Stephen Havard, and Tanya Rogers.

Chemical engineering student teams from around the country were challenged to design and construct a size-limited car that is powered by a controlled chemical reaction. The car’s performance was evaluated by its ability to travel a specified distance of 21 meters with a load measuring 300 milliliters. Distance and load parameters were given to the teams an hour before the competition.

“Our 29-pound car had some mechanical issues on the first run, but it was quickly sorted out and we had a thrilling second run as the Zombie Cougalac sped off, then stopped 0.41 meters from the line,” said Dinh.

Since the UH team’s second-place win in the regional competition in April, the entire car was rebuilt to make it more competitive at the national level. “Many of the new components were chosen for an even greater level of safety and reliability,” said Dinh.

The team converted all of the car’s materials to either stainless or aluminum for chemical compatibility. As a commitment to US manufacturing, the team sourced parts and supplies produced domestically.

See the Chem-E Car interview, featuring team member Rishabh Mahajan describing the car's mechanics.

See full 2012 National Chem-E Car results.

Department: 

Related News Stories

Researcher Publishes Paper on Engineered Antibody that Targets Acute Myeloid Leukemia

Almost 19,000 new cases of acute myeloid leukemia and 10,500 deaths from the blood and bone marrow cancer could strike Americans this year, according to the American Cancer Society. Chemotherapy, when used as primary treatment, is successful in about 65 percent of patients with the cancer, and remission rates vary depending on patients’ individual characteristics, according to the organization.

Upcoming Events / Seminars

Archived News